MSB 3.76% $1.03 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-551

  1. 30,280 Posts.
    lightbulb Created with Sketch. 1822
    This is only an advisory committee and it's the first stem cell approval application so they're being bureaucrats and scared of what they don't fully understand. Oddly enough some of the nayasyers in here have referred to these claims before..

    Storm in a teacup but great for the shorters.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.